Aandelen in “Testlaboratoria”

Aandeel Datum Koers Evolutie
vlag Genedrive Plc 25/08 1,300 GBX
-5,80% 		-5,80%
vlag Gerresheimer AG 25/08 25,580 EUR
-8,71% 		-8,71%

Nieuws over “Testlaboratoria”

19/08 · Pentwater Capital Management LP - Form 8.3 - Intertek Group Plc · Persbericht

19/08 · Pentwater Capital Management LP - Form 8.3 - Intertek Group Plc · Persbericht

17/08 · Pentwater Capital Management LP - Form 8.3 - Intertek Group Plc · Persbericht

13/08 · Norges Bank - Form 8.3 - Intertek Group Plc · Persbericht

7/08 · Pentwater Capital Management LP - Form 8.3 - Intertek Group Plc · Persbericht

6/08 · 10x Genomics Reports Second Quarter 2026 Financial Results · Persbericht

3/08 · WENDEL: Information on David Darmon’s departure · Persbericht

30/07 · WENDEL: David Darmon, Group Deputy CEO and member of Wendel’s Executive Board, will leave his position on November 30, 2026 · Persbericht

30/07 · WENDEL: 2026 Half-Year Results · Persbericht

29/07 · 10x Genomics and Lausanne University Hospital Collaborate to Advance Research in Diagnostic Applications of Single Cell and Spatial Technologies for Cancer Care · Persbericht

28/07 · Pentwater Capital Management LP - Form 8.3 - Intertek Group Plc · Persbericht

28/07 · Norges Bank - Form 8.3 - Intertek Group Plc · Persbericht

27/07 · Pentwater Capital Management LP - Form 8.3 - Intertek Group Plc · Persbericht

22/07 · Norges Bank - Form 8.3 - Intertek Group Plc · Persbericht

21/07 · Norges Bank - Form 8.3 - Intertek Group Plc · Persbericht

20/07 · Norges Bank - Form 8.3 - Intertek Group Plc · Persbericht

15/07 · 10x Genomics to Report Second Quarter 2026 Financial Results on August 6, 2026 · Persbericht

15/07 · Norges Bank - Form 8.3 - Intertek Group Plc · Persbericht

14/07 · Norges Bank - Form 8.3 - Intertek Group Plc · Persbericht

10/07 · Norges Bank - Form 8.3 - Intertek Group Plc · Persbericht

9/07 · Norges Bank - Form 8.3 - Intertek Group Plc · Persbericht

Mijn selecties